In this case series four patients—two children with hypoxic–ischemic brain injury, an adult with optic glioma-induced visual loss, and a child with severe crush syndrome—received NGF therapy after failing to recover with standard treatments. This evidence concerns the gene NGF and Crush Syndrome.